SCHEMBL3377816

SCHEMBL3377816

CC(C)(C)NC(=O)c1c(OS(=O)(=O)C(F)(F)F)cccc1C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 2/20 0.39
ALOX15 P16050 1/20 0.39
HPGD P15428 3/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPK1 P28482 2/20 0.39
ALDH1A1 P00352 2/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
DRD2 P14416 2/20 0.37
HTR1D P28221 2/20 0.37
DRD3 P35462 2/20 0.37
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
HSD17B10 Q99714 1/20 0.35
FABP3 P05413 1/20 0.34
FABP4 P15090 1/20 0.34
FABP5 Q01469 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3377822 0.90 MAPT (0.42) KMT2AMAPTMEN1ALOX15HPGD
SCHEMBL3374452 0.87 ALOX15 (0.41) KMT2AMAPTMEN1ALOX15HPGD
SCHEMBL3377632 0.85 NPSR1 (0.37) MAPTALOX15HPGDKDM4EDRD2
SCHEMBL3379105 0.85 NPSR1 (0.40) MAPTALOX15HPGDKDM4EALDH1A1
SCHEMBL3377686 0.85 NPSR1 (0.40) KMT2AMAPTMEN1ALOX15HPGD
SCHEMBL3377416 0.81 DRD2 (0.47) KMT2AMEN1MAPK1ALDH1A1DRD2
SCHEMBL3373446 0.81 MEN1 (0.45) KMT2AMEN1HPGDKDM4EMAPK1
SCHEMBL3376132 0.81 POLB (0.43) KMT2AMEN1HPGDKDM4EGAA
SCHEMBL3378263 0.80 TSHR (0.47) KMT2AMEN1HPGDKDM4EALDH1A1
SCHEMBL3374780 0.79 POLB (0.39) KMT2AMEN1HPGDKDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517886-B1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-11-10 EP disclosed
US-7132455-B2 Phthalamide derivatives BAYER CROPSCIENCE AG (DE) 2006-11-07 US disclosed
US-20060035967-A1 Novel phthalamide derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2006-02-16 US disclosed
EP-1517886-A1 NOVEL PHTHALAMIDE DERIVATIVES Bayer CropScience AG (DE) 2005-03-30 EP disclosed
WO-2004000796-A1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060035967-A1 Novel phthalamide derivatives HDAC1, HDAC2, CRY1 KMT2A 102/4885MAPT 521/4885MEN1 1772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.